Dr. Rossetti on Symptom Management for MPNs

Video

In Partnership With:

James M. Rossetti, DO, discusses symptom management for patients with myeloproliferative neoplasms.

James M. Rossetti, DO, hematologist, UPMC Hillman Cancer Center, discusses symptom management for patients with myeloproliferative neoplasms (MPNs).

Symptom management largely relates to the disease that the person has, explains Rossetti. The patient needs to have their symptoms assessed to see which ones might be related to the disease. According to Rossetti, many patients with MPNs feel they do not receive an accurate diagnosis for several years with vague symptoms. Even low-risk disease can cause significant symptoms, including cytokine release syndrome and others.

Some agents, such as ruxolitinib (Jakafi), help with symptom management in patients with myelofibrosis and polycythemia vera. Aspirin can also manage many symptoms, according to Rossetti. Ultimately, looking at other antiplatelet therapies and looking at new agents might help patients with MPNs with their symptoms, concludes Rossetti.

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine